News
The company also encounters competitive risks from other organizations developing therapies for chronic kidney disease.
MarketWatch on MSN17h
Microsoft’s stock gets an upgrade. Why these analysts say it’s underappreciated in AI.Microsoft Corp.’s stock was upgraded on Wednesday by analysts who expect investor interest in the company’s ...
Unlike conventional hyperscalers like Amazon’s AWS or Microsoft's Azure that provide a wide range of general-purpose cloud ...
Fed minutes and copper are in focus Wednesday as stocks look to shake of tariff anxiety and rally to fresh record highs.
Federal Housing Finance Agency director Bill Pulte announced that lenders may start using VantageScore, a rival to the Fair ...
Admittedly, in the relative near term, it’s difficult to frame U stock as cheap. In the past 52 weeks, for example, the ...
Explore more
Stock futures are pointing to a slightly higher open on Wednesday after a sluggish start to the week amid uncertainty about U ...
The stunning rise of Nvidia Corp to become the first publicly traded company valued at $4 trillion underscores the massive ...
21hon MSN
Tax incentives contained in the sweeping tax and budget bill Trump signed on July 4 could provide a fresh boost to AI ...
The scam revolves around a "ramp-and-dump" scheme that targets people through unsolicited investment club offers.
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the company announced ...
According to the complaint filed in U.S. District Court for the Northern District of California, Bal was an early investor in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results